22nd Mar 2021 16:17
Ap19
FORM 8.3 - Amendment to purchase and sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 18 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,808,123 | 1.40% | 184,235 | 0.14% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,935 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,917,158 | 1.49% | 197,401 | 0.15% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 221.1800 USD |
Purchase | 4 | 220.5850 USD |
Purchase | 4 | 221.2462 USD |
Purchase | 10 | 221.3700 USD |
Purchase | 14 | 220.9100 USD |
Purchase | 14 | 220.8946 USD |
Purchase | 16 | 222.7587 USD |
Purchase | 30 | 221.0383 USD |
Purchase | 50 | 221.2700 USD |
Purchase | 50 | 220.3300 USD |
Purchase | 100 | 221.1900 USD |
Purchase | 100 | 221.2550 USD |
Purchase | 100 | 221.6300 USD |
Purchase | 103 | 220.7736 USD |
Purchase | 129 | 221.3306 USD |
Purchase | 143 | 220.8302 USD |
Purchase | 197 | 221.0220 USD |
Purchase | 218 | 221.3697 USD |
Purchase | 319 | 220.9500 USD |
Purchase | 518 | 220.7987 USD |
Purchase | 600 | 220.8650 USD |
Purchase | 1,111 | 221.1592 USD |
Purchase | 2,361 | 220.9762 USD |
Purchase | 3,293 | 221.0187 USD |
Purchase | 6,649 | 220.9712 USD |
Purchase | 8,503 | 221.1400 USD |
Purchase | 8,690 | 221.0152 USD |
Purchase | 8,944 | 221.1661 USD |
Purchase | 11,485 | 221.1269 USD |
Purchase | 12,810 | 221.1839 USD |
Purchase | 12,966 | 221.0120 USD |
Sale | 1 | 221.1800 USD |
Sale | 1 | 221.6200 USD |
Sale | 52 | 221.0700 USD |
Sale | 87 | 221.4377 USD |
Sale | 90 | 221.1488 USD |
Sale | 99 | 221.3800 USD |
Sale | 100 | 220.8500 USD |
Sale | 100 | 220.9403 USD |
Sale | 100 | 221.1100 USD |
Sale | 100 | 221.2500 USD |
Sale | 102 | 221.3606 USD |
Sale | 110 | 221.2655 USD |
Sale | 167 | 221.2195 USD |
Sale | 200 | 220.8490 USD |
Sale | 200 | 221.0900 USD |
Sale | 201 | 221.2433 USD |
Sale | 257 | 221.0331 USD |
Sale | 267 | 221.3782 USD |
Sale | 300 | 220.4266 USD |
Sale | 300 | 221.2900 USD |
Sale | 419 | 221.2242 USD |
Sale | 480 | 220.9787 USD |
Sale | 599 | 221.2536 USD |
Sale | 623 | 221.1774 USD |
Sale | 889 | 221.2362 USD |
Sale | 989 | 221.1442 USD |
Sale | 1,337 | 221.2416 USD |
Sale | 1,344 | 220.9152 USD |
Sale | 1,637 | 221.1812 USD |
Sale | 2,161 | 220.9694 USD |
Sale | 3,362 | 221.1285 USD |
Sale | 3,442 | 221.1801 USD |
Sale | 3,462 | 221.0723 USD |
Sale | 4,155 | 220.9048 USD |
Sale | 4,535 | 221.1163 USD |
Sale | 6,405 | 221.1839 USD |
Sale | 10,923 | 221.0114 USD |
Sale | 14,149 | 221.0292 USD |
Sale | 15,141 | 221.1400 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 22 Mar 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210322005621/en/
Copyright Business Wire 2021
Related Shares:
Barclays